1. Li L, Bai L, Lin H, Dong L, Zhang R, Cheng X, Liu Z, Ouyang Y, Ding K*. Multiomics analysis of tumor mutational burden across cancer types. Comput Struct Biotechnol J. 2021 Oct 12;19:5637-5646. (*Corresponding Author)(IF=7.271)
2. Zhu Y, Zhang R, Zhang Y, Cheng X, Li L, Wu Z, Ding K*. NUDT21 Promotes Tumor Growth and Metastasis Through Modulating SGPP2 in Human Gastric Cancer. Front Oncol. 2021 Sep 30;11:670353. (*Corresponding Author)(IF=6.244)
3. Shi X#, Ding K#, Zhao Q, Li P, Kang Y, Tan S, Sun J. Suppression of CPSF6 Enhances Apoptosis Through Alternative Polyadenylation-Mediated Shortening of the VHL 3'UTR in Gastric Cancer Cells. Front Genet. 2021 Sep 14;12:707644. (# Co-first Author)(IF=4.599)
4. Yan Y, Cheng X, Li L, Zhang R, Zhu Y, Wu Z, Ding K*. A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo. Front Oncol. 2021 May 12;11:669393. (*Corresponding Author)(IF=6.244)
5. Xiang R, Han X, Ding K*, Wu Z*. CMIP promotes Herceptin resistance of HER2 positive gastric cancer cells. Pathol Res Pract. 2020 Feb;216(2):152776. (*Corresponding Author)(IF=3.25)
6. Cheng X, Wang X, Wu Z, Tan S, Zhu T, Ding K*. CORO1C expression is associated with poor survival rates in gastric cancer and promotes metastasis in vitro. FEBS Open Bio. 2019 Jun;9(6):1097-1108. (*Corresponding Author) (IF=2.693)
7. Ding K, Wu Z, Li X, Sheng Y, Wang X, Tan S. LMO4 mediates trastuzumab resistance in HER2 positive breast cancer cells. Am J Cancer Res. 2018 Apr 1;8(4):594-609. (IF=6.166)
8. Ding K, Tan S, Huang X, Wang X, Li X, Fan R, Zhu Y, Lobie PE, Wang W, Wu Z. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. J Biol Chem. 2018 Jan 24. pii:jbc.RA117.001103. (IF=5.157)
9. Tan S#, Ding K#, Chong QY, Zhao J, Liu Y, Shao Y, Zhang Y, Yu Q, Xiong Z, Zhang W, Zhang M, Li G, Li X, Kong X, Ahmad A, Wu Z, Wu Q, Zhao X, Lobie PE, Zhu T. Post-tranional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells. J Biol Chem. 2017 Aug 18;292(33):13551-13564. (# Co-first Author) (IF=5.157)
10. Ding K, Yuan Y, Chong QY, Yang Y, Li R, Li X, Kong X, Qian P, Xiong Z, Pandey V, Ma L, Wu Z, Lobie PE, Zhu T. Autocrine Prolactin Stimulates Endometrial Carcinoma Growth and Metastasis and Reduces Sensitivity to Chemotherapy. Endocrinology. 2017 Jun 1;158(6):1595-1611. (IF=4.736)
11. Ding K, Wu Z, Wang N, Wang X, Wang Y, Qian P, Meng G, Tan S. MiR-26a performs converse roles in proliferation and metastasis of different gastric cancer cells via regulating of PTEN expression. Pathol Res Pract. 2017 May;213(5):467-475. (IF=3.25)
12. Lü M#, Ding K#, Zhang G, Yin M, Yao G, Tian H, Lian J, Liu L, Liang M, Zhu T, Sun F. MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ. Sci Rep. 2015 Mar 4;5:8735.(# Co-first Author) (IF=4.379)
13. Ding K, Banerjee A, Tan S, Zhao J, Zhuang Q, Li R, Qian P, Liu S, Wu ZS, Lobie PE, Zhu T. Artemin, a Member of the Glial Cell Line-derived Neurotrophic Factor Family of Ligands, Is HER2-regulated and Mediates Acquired Trastuzumab Resistance by Promoting Cancer Stem Cell-[like] Behavior in Mammary Carcinoma Cells. J Biol Chem. 2014 Jun 6;289(23):16057-71. (IF=5.157)
14. Tan S#, Ding K#, Li R, Zhang W, Li G, Kong X, Qian P, Lobie PE, Zhu T. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2. Breast Cancer Res. 2014 Apr 15;16(2):R40. (#Co-first Author) (IF=6.466)
15. Zhang Y, Sun Y, Ding L, Shi W, Ding K, Zhu Y. Long Non-Coding RNA LINC00467 Correlates to Poor Prognosis and Aggressiveness of Breast Cancer. Front Oncol. 2021 Apr 28;11:643394. (IF=6.244)
16. Tan S, Zhang M, Shi X, Ding K, Zhao Q, Guo Q, Wang H, Wu Z, Kang Y, Zhu T, Sun J, Zhao X. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression. J Exp Clin Cancer Res. 2021 Mar 1;40(1):85. (IF=11.161)
17. Zhang W, Wu M, Chong QY, Zhang M, Zhang X, Hu L, Zhong Y, Qian P, Kong X, Tan S, Li G, Ding K, Lobie PE, Zhu T. Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer. Cancer Res. 2018 Sep 1;78(17):4915-4928. (IF=12.701)
18. Tan S, Li H, Zhang W, Shao Y, Liu Y, Guan H, Wu J, Kang Y, Zhao J, Yu Q, Gu Y, Ding K, Zhang M, Qian W, Zhu Y, Cai H, Chen C, Lobie PE, Zhao X, Sun J, Zhu T. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression. Oncogene. 2018 Aug;37(35):4887-4900. (IF=9.867)
19. Chen C, Lei J, Zheng Q, Tan S, Ding K, Yu C. Poly(rC) binding protein 2 (PCBP2) promotes the viability of human gastric cancer cells by regulating CDK2. FEBS Open Bio. 2018 Mar 22;8(5):764-773. (IF=2.693)
20. Chen P, He YH, Huang X, Tao SQ, Wang XN, Yan H, Ding KS, Lobie PE, Wu WY, Wu ZS. MiR-23a modulates X-linked inhibitor of apoptosis-mediated autophagy in human luminal breast cancer cell lines. Oncotarget. 2017 Sep 19;8(46):80709-80721. (IF=5.168)
21. Li G, Wu X, Qian W, Cai H, Sun X, Zhang W, Tan S, Wu Z, Qian P, Ding K, Lu X, Zhang X, Yan H, Song H, Guang S, Wu Q, Lobie PE, Shan G, Zhu T. CCAR1 5' UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance. Cell Res. 2016 Jun;26(6):655-73. (IF=25.617)
22. Chai P, Tian J, Zhao D, Zhang H, Cui J, Ding K, Liu B. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion. Biochem Biophys Res Commun. 2016 Feb 26;471(1):123-8. (IF=3.575)
23. Zhang W, Qian P, Zhang X, Zhang M, Wang H, Wu M, Kong X, Tan S, Ding K, Perry JK, Wu Z, Cao Y, Lobie PE, Zhu T. Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer. J Biol Chem. 2015 May 29;290(22):13812-29. (IF=5.157)
24. Jiang Y, Zhao X, Xiao Q, Liu Q, Ding K, Yu F, Zhang R, Zhu T, Ge G. Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR-ERK independent of epithelial-mesenchymal transition. J Mol Cell Biol. 2014 Aug;6(4):352-4 (IF=6.216)
25. Tan S, Li R, Ding K, Lobie PE, Zhu T. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. FEBS Lett. 2011 Jul 21;585(14):2229-34. (IF=4.124)
